These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1357 related articles for article (PubMed ID: 31369817)

  • 21. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
    Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
    Front Immunol; 2020; 11():1280. PubMed ID: 32849491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem cell epigenetics and chemoresistance.
    Crea F; Danesi R; Farrar WL
    Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer Stem Cell (CSC) Inhibitors in Oncology-A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives.
    Kharkar PS
    J Med Chem; 2020 Dec; 63(24):15279-15307. PubMed ID: 33325699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
    Begicevic RR; Falasca M
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29117122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
    Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
    Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptotic and autophagic pathways with relevant small-molecule compounds, in cancer stem cells.
    Zhang L; Tong X; Li J; Huang Y; Hu X; Chen Y; Huang J; Wang J; Liu B
    Cell Prolif; 2015 Aug; 48(4):385-97. PubMed ID: 26013704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptotic death of cancer stem cells for cancer therapy.
    He YC; Zhou FL; Shen Y; Liao DF; Cao D
    Int J Mol Sci; 2014 May; 15(5):8335-51. PubMed ID: 24823879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABCG2: the key to chemoresistance in cancer stem cells?
    An Y; Ongkeko WM
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1529-42. PubMed ID: 19708828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance.
    Chen K; Zhang C; Ling S; Wei R; Wang J; Xu X
    Cell Death Dis; 2021 Sep; 12(9):835. PubMed ID: 34482364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABC transporters, drug resistance, and cancer stem cells.
    Dean M
    J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):3-9. PubMed ID: 19224345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes.
    Ma X; Zhou J; Zhang CX; Li XY; Li N; Ju RJ; Shi JF; Sun MG; Zhao WY; Mu LM; Yan Y; Lu WL
    Biomaterials; 2013 Jun; 34(18):4452-65. PubMed ID: 23518403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
    Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
    Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.